Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › reldesemtiv

reldesemtiv

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of reldesemtiv

2 trials tracked of reldesemtiv.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 2
  1. Phase 2 A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease Completed
  2. Phase 2 A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Reeldesemtiv showed no impact on device use in ALS trial terminated early for futility
Drug Pipeline RCT
Reeldesemtiv showed no impact on device use in ALS trial terminated early for futility Wheelchair access varies wildly, and drug trial ended early without benefit for ALS patients
This Phase 3 randomized clinical trial enrolled 482 participants with amyotrophic lateral sclerosis (ALS) across 83 sites.
Access to wheelchairs differs greatly by region, and a major drug trial for ALS stopped early because it did not help patients.
Apr 24, 2026